{"count": 4, "results": [{"_id": "40035222", "pmid": 40035222, "title": "An overview of insulin therapy for the non-specialist.", "journal": "Diabetes Obes Metab", "authors": ["Home PD"], "date": "2025-03-04T00:00:00Z", "doi": "10.1111/dom.16280", "meta_date_publication": "2025 Mar 4", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50221.62, "text_hl": "Basal and meal-time preparations of pharmaceutical @GENE_INS @GENE_3630 @@@insulin@@@ analogues are also used for T2DM, with GLP-1RA and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ usually continued. ", "citations": {"NLM": "Home PD. An overview of insulin therapy for the non-specialist. Diabetes Obes Metab. 2025 Mar 4;():. PMID: 40035222", "BibTeX": "@article{40035222, title={An overview of insulin therapy for the non-specialist.}, author={Home PD}, journal={Diabetes Obes Metab}}"}}, {"_id": "10063324", "pmid": 10063324, "title": "[Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data].", "journal": "Minerva Endocrinol", "authors": ["Galeone F", "Fiore G", "Arcangeli A", "Mannucci E"], "date": "1998-09-01T00:00:00Z", "meta_date_publication": "1998 Sep", "meta_volume": "23", "meta_issue": "3", "meta_pages": "71-5", "score": 50061.938, "text_hl": "The @SPECIES_9606 @@@patients@@@ were treated with @CHEMICAL_Gliclazide @CHEMICAL_MESH:D005907 @@@gliclazide@@@ 120 mg/day and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 1500 mg/day for 3 months; HbA1c, 24-hour @<m>DISEASE_Glycosuria</m> @DISEASE_MESH:D006029 @@@glycosuria@@@, and fasting and post-prandial glycaemia, were determined at the beginning and at the end of the study. ", "citations": {"NLM": "Galeone F, Fiore G, Arcangeli A, Mannucci E. [Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data]. Minerva Endocrinol. 1998 Sep;23(3):71-5. PMID: 10063324", "BibTeX": "@article{10063324, title={[Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data].}, author={Galeone F and Fiore G and Arcangeli A and Mannucci E}, journal={Minerva Endocrinol}, volume={23}, number={3}, pages={71-5}}"}}, {"_id": "574098", "pmid": 574098, "title": "Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment.", "journal": "Diabete Metab", "authors": ["De Silva SR", "Betteridge DJ", "Shawe JE", "Cudworth AG", "Alberti KG"], "date": "1979-09-01T00:00:00Z", "meta_date_publication": "1979 Sep", "meta_volume": "5", "meta_issue": "3", "meta_pages": "223-9", "score": 50056.145, "text_hl": "A more significant improvement in fasting blood @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ and @<m>DISEASE_Glycosuria</m> @DISEASE_MESH:D006029 @@@glycosuria@@@ occured with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and combined therapy. ", "citations": {"NLM": "De Silva SR, Betteridge DJ, Shawe JE, Cudworth AG, Alberti KG. Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment. Diabete Metab. 1979 Sep;5(3):223-9. PMID: 574098", "BibTeX": "@article{574098, title={Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment.}, author={De Silva SR and Betteridge DJ and Shawe JE and Cudworth AG and Alberti KG}, journal={Diabete Metab}, volume={5}, number={3}, pages={223-9}}"}}, {"_id": "27691959", "pmid": 27691959, "title": "TREATMENT OF DIABETES MELLITUS IN A GOLDEN LION TAMARIN (LEONTOPITHECUS ROSALIA) WITH THE GLUCAGON-LIKE PEPTIDE-1 MIMETIC EXENATIDE.", "journal": "J Zoo Wildl Med", "authors": ["Johnson JG 3rd", "Langan JN", "Gilor C"], "date": "2016-09-01T00:00:00Z", "doi": "10.1638/2015-0270.1", "meta_date_publication": "2016 Sep", "meta_volume": "47", "meta_issue": "3", "meta_pages": "903-906", "score": 50054.68, "text_hl": "An 8-yr-old male @SPECIES_30588 @@@golden lion tamarin@@@ ( @SPECIES_30588 @@@Leontopithecus rosalia@@@ ) was diagnosed with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@ based on @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and persistent @<m>DISEASE_Glycosuria</m> @DISEASE_MESH:D006029 @@@glycosuria@@@. Initial treatment consisted of the oral antihyperglycemic medications @CHEMICAL_Glipizide @CHEMICAL_MESH:D005913 @@@glipizide@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ that resulted in decreased @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@ concentrations; however, marked @<m>DISEASE_Glycosuria</m> @DISEASE_MESH:D006029 @@@glycosuria@@@ persisted. ", "citations": {"NLM": "Johnson JG 3rd, Langan JN, Gilor C. TREATMENT OF DIABETES MELLITUS IN A GOLDEN LION TAMARIN (LEONTOPITHECUS ROSALIA) WITH THE GLUCAGON-LIKE PEPTIDE-1 MIMETIC EXENATIDE. J Zoo Wildl Med. 2016 Sep;47(3):903-906. PMID: 27691959", "BibTeX": "@article{27691959, title={TREATMENT OF DIABETES MELLITUS IN A GOLDEN LION TAMARIN (LEONTOPITHECUS ROSALIA) WITH THE GLUCAGON-LIKE PEPTIDE-1 MIMETIC EXENATIDE.}, author={Johnson JG 3rd and Langan JN and Gilor C}, journal={J Zoo Wildl Med}, volume={47}, number={3}, pages={903-906}}"}}]}